(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
10.28% $ 2.36
Live Chart Being Loaded With Signals
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally...
Stats | |
---|---|
Volumen de hoy | 25 629.00 |
Volumen promedio | 13 216.00 |
Capitalización de mercado | 4.47M |
EPS | $0 ( 2024-05-02 ) |
Last Dividend | $0.850 ( 2022-12-19 ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.270 |
ATR14 | $0.0230 (0.97%) |
Medigus Ltd. Correlación
10 Correlaciones Más Positivas | |
---|---|
TLGT | 0.948 |
ZIOP | 0.902 |
QTEK | 0.901 |
TRMT | 0.901 |
SKYX | 0.9 |
CFFI | 0.897 |
PACB | 0.897 |
ALLR | 0.896 |
VEEE | 0.895 |
JACK | 0.892 |
10 Correlaciones Más Negativas | |
---|---|
VLATU | -0.929 |
ALSK | -0.927 |
XFIN | -0.923 |
CSLM | -0.919 |
ENTF | -0.918 |
FEXD | -0.914 |
GBDC | -0.913 |
AMTBB | -0.911 |
VCTR | -0.911 |
IGTA | -0.909 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Medigus Ltd. Finanzas
Annual | 2022 |
Ingresos: | $91.86M |
Beneficio Bruto: | $14.45M (15.73 %) |
EPS: | $-6.28 |
FY | 2022 |
Ingresos: | $91.86M |
Beneficio Bruto: | $14.45M (15.73 %) |
EPS: | $-6.28 |
FY | 2021 |
Ingresos: | $10.12M |
Beneficio Bruto: | $4.80M (47.45 %) |
EPS: | $3.00 |
FY | 2019 |
Ingresos: | $273 000 |
Beneficio Bruto: | $-182 000 (-66.67 %) |
EPS: | $-54.44 |
Financial Reports:
No articles found.
Medigus Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0.850 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.850 | 2022-12-19 |
Last Dividend | $0.850 | 2022-12-19 |
Next Dividend | $0 | N/A |
Payout Date | 2022-12-28 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.850 | -- |
Avg. Dividend % Per Year | 0.87% | -- |
Score | 0.36 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2022 | $0.850 | 5.20% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.135 | 1.500 | -2.70 | -4.05 | [0 - 0.5] |
returnOnAssetsTTM | -0.218 | 1.200 | -7.27 | -8.72 | [0 - 0.3] |
returnOnEquityTTM | -0.527 | 1.500 | -6.97 | -10.00 | [0.1 - 1] |
payoutRatioTTM | -0.269 | -1.000 | -2.69 | 2.69 | [0 - 1] |
currentRatioTTM | 1.297 | 0.800 | 8.51 | 6.81 | [1 - 3] |
quickRatioTTM | 1.221 | 0.800 | 7.52 | 6.02 | [0.8 - 2.5] |
cashRatioTTM | 0.344 | 1.500 | 9.20 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.135 | -1.500 | 7.74 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -4.72 | 1.000 | -2.86 | -2.86 | [3 - 30] |
operatingCashFlowPerShareTTM | -4.67 | 2.00 | -1.557 | -3.11 | [0 - 30] |
freeCashFlowPerShareTTM | -5.75 | 2.00 | -2.88 | -5.75 | [0 - 20] |
debtEquityRatioTTM | 0.365 | -1.500 | 8.54 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.150 | 1.000 | -0.833 | -0.833 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0864 | 1.000 | -3.73 | -3.73 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.658 | 1.000 | -4.77 | -4.77 | [0.2 - 2] |
assetTurnoverTTM | 1.616 | 0.800 | 2.56 | 2.05 | [0.5 - 2] |
Total Score | -0.264 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.206 | 1.000 | -0.122 | 0 | [1 - 100] |
returnOnEquityTTM | -0.527 | 2.50 | -4.48 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -5.75 | 2.00 | -1.918 | -5.75 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -4.67 | 2.00 | -1.557 | -3.11 | [0 - 30] |
payoutRatioTTM | -0.269 | 1.500 | -2.69 | 2.69 | [0 - 1] |
pegRatioTTM | -0.00224 | 1.500 | -3.35 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0551 | 1.000 | -3.88 | 0 | [0.1 - 0.5] |
Total Score | -3.00 |
Medigus Ltd.
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it develops, markets, and distributes software for internet users; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, visualization solutions, and resistant cameras; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico